<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="activity_corpus\PMC8126690\results\search\activity\results.xml">
  <result pre="herbs have gained prominence in ethnomedicine as attractive choices for" exact="antiviral" post="therapies (Utomo et al., 2020). Some polyphenols, a subset"/>
  <result pre="been proposed, including demography, climate, genetic variations, cross immunity, and" exact="antimalarial" post="usage (Lalaoui et al., 2020). FIGURE 1 Geographical distribution"/>
  <result pre="II (a vasoconstrictor peptide) into angiotensin (1â€&quot;7) which is a" exact="vasodilator" post="that lowers the blood pressure (Verdecchia et al., 2020)."/>
  <result pre="response, homeostasis of the intestinal microbiota and regulatory expression of" exact="antimicrobial" post="peptides. Consequently, a secondary infection by bacteria may also"/>
  <result pre="2020) indicating the important roles of ACE2. ACE2 as a" exact="Therapeutic" post="Target Though, a focus on the ACE2 activity accompanying"/>
  <result pre="ACE2 receptor have been explored (Glasgow et al., 2020). These" exact="agents" post="have shown superior neutralizing efficiency to convalescent sera (Glasgow"/>
  <result pre="long been considered as important sources of therapeutic agents. These" exact="agents" post="are remarkably low molecular weight molecules capable of eliciting"/>
  <result pre="(Daak et al., 2020). The ACE2 activities of these bioactive" exact="agents" post="have been demonstrated in previous studies. Ulu and co-workers"/>
  <result pre="tissue bioavailability of most peptides limits theirs use as therapeutic" exact="agents" post="(Campos et al., 2011). To address this, approaches like"/>
  <result pre="from lemon grass, ginger, and neem leaves. Notably, like synthetic" exact="agents" post="for COVID-19 such as remdesivir, dexamethasone and chloroquine, some"/>
  <result pre="(virion fusion and entry) along the Spike-RBD/TMPRSS2/ACE2 axis. These phytomedicinal" exact="agents" post="include those that may 1) interfere with host cell"/>
  <result pre="represent another turning point for COVID-19 therapeutics. TABLE 3 Plant" exact="derivatives" post="with potential effect on the Spike-RBD/TMPRSS2/ACE2 axis. Target Plant"/>
  <result pre="propagation by inhibiting TMPRSS2 Kumar et al. (2020c) Possible drug-able" exact="agents" post="for prevention and therapeutics aThese compounds were found to"/>
  <result pre="RBD For COVID-19, it is more logical to find phytomedicinal" exact="agents" post="that specifically target the interaction of RBD at the"/>
  <result pre="complex and not particular to ACE2. This caution is because" exact="agents" post="solely targeting ACE2 may interfere with ACE2 enzyme activity"/>
  <result pre="angle for exploration, which may achieve satisfactory outcomes. Safety Phytomedicinal" exact="agents" post="investigated against the Spike-RBD/TMPRSS2/ACE2 axis have displayed beneficial pharmacokinetic"/>
  <result pre="provide experimental basis for the research and development/promotion of natural" exact="antiviral" post="drugs/nutrition. The cytotoxic status of a plant is also"/>
  <result pre="al., 2020). Additionally, most plant products highlighted are very promising" exact="agents" post="keeping in view their pre-reported biological benefits. Thus, further"/>
  <result pre="(2020b). In-silico investigation of phytochemicals from Asparagus racemosus as plausible" exact="antiviral" post="agent in COVID-19. J. Biomol. Struct. Dyn., 1â€&quot;15 .10.1080/07391102.2020.1784289"/>
  <result pre="rat. NPJ Sci. Food3, 1. 10.1038/s41538-018-0033-531304273 HellingerR.GruberC. W. (2019). Peptide-based" exact="protease inhibitors" post="from plants. Drug Discov. Today24 (9), 1877â€&quot;1889. 10.1016/j.drudis.2019.05.02631170506 HoT.WuS.ChenJ.LiC.HsiangC."/>
  <result pre="ACE2 and TMPRSS2 and is blocked by a clinically proven" exact="protease inhibitor." post="Cell181 (2), 271â€&quot;280. 10.1016/j.cell.2020.02.05232142651 HuangC.WangY.LiX.RenL.ZhaoJ.HuY.et al. (2020). Clinical features"/>
  <result pre="mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to" exact="ACE inhibitors." post="Can. J. Physiol. Pharmacol.80 (4), 346â€&quot;353. 10.1139/y02-02112025971 TutunchiH.NaeiniF.OstadrahimiA.Hosseinzadehâ€�AttarM. J."/>
  <result pre="(4), 346â€&quot;353. 10.1139/y02-02112025971 TutunchiH.NaeiniF.OstadrahimiA.Hosseinzadehâ€�AttarM. J. (2020). Naringenin, a flavanone with" exact="antiviral" post="and antiâ€�inflammatory effects: a promising treatment strategy against COVID"/>
 </snippets>
</snippetsTree>
